MARQUIS Antiprotozoal Oral Paste is the first FDA-approved treatment for equine protozoal myeloencephalitis (EPM). Treat EPM with confidence.
Marquis (ponazuril) is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. DOSAGE: Marquis (15% w/w
EPM, Laminitis, Equine Metabolic Syndrome. Case Description: An 8-yr EPM medication, Marquis. This was handled as 2 claims but for the sake of
MARQUIS for horses is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona.
Marquis (Ponazuril) oral paste for the treatment of EPM (Equine Protozoal Myeloencephalitis). Each gram of Marquis delivers 150 mg of ponazuril. Comes in
Treat your horse's EPM with Marquis Antiprotozoal Oral Paste. Marquis is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by
MARQUIS for horses is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona.
MARQUIS is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona.
Marquis (ponazuril) Antiprotozoal Oral Paste is used for the treatment of EPM (Equine Protozoal Myeloencephalitis) in horses.
Comments